Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells. It is grouped under the following drug class(es): Sickle cell agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include mitapivatum and PK-R Activator AG-348. Its PubChem CID is 59634741.
Mitapivat
| CAS No | 1260075-17-9 |
|---|---|
| Molecular Formula | C24H26N4O3S |
| Molecular Weight | 450.60 g/mol |
| Synonyms | N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells.
The listed CAS number is 1260075-17-9.
The listed molecular formula is C24H26N4O3S.
The listed molecular weight is 450.60 g/mol.
N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide.
The source lists mitapivatum and PK-R Activator AG-348.